Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Engelhardt

Showing results (71-80 of 226) with videos related to

Pageof 23
Sort By:
Leukemia Research|June 21, 2011
Early and mature endothelial progenitors and VEGFR2+-cells in multiple myeloma: association with disease characteristics and variation in different cell compartmentsJosefina Udi, Dagmar Wider, Martina Kleber, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 21, 2020
Real-World Evaluation of Health-Related Quality of Life in Patients With Multiple Myeloma From GermanyMonika Engelhardt, Gabriele Ihorst, Moushmi Singh, et al.
British Journal of Haematology|May 27, 2022
Favourable outcomes of double-hit/double-expressor lymphoma and high-grade B-cell lymphoma, not otherwise specified after early dose-intensive treatment and up-front autologous stem cell transplantation: a single-centre retrospective experienceTim Strüßmann, Franziska Glatzki, Monika Engelhardt, et al.
Cancers|December 17, 2024
Clinical Characteristics, Cytogenetic Risks, and Prognoses of Young Multiple Myeloma Patients in the Era of Novel TherapiesNathalie Borst, Gabriele Ihorst, Sina Wenger, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2013
Validation of the Freiburg Comorbidity Index in 466 multiple myeloma patients and combination with the international staging system are highly predictive for outcomeMartina Kleber, Gabriele Ihorst, Barbara Gross, et al.
Annals of Hematology|March 26, 2018
Diffuse large B cell lymphoma (DLBCL): bilateral vanishing tibiaeReinhard Marks, Monika Engelhardt, Sven Hager, et al.
Cancer|February 7, 2018
Current developments in immunotherapy in the treatment of multiple myelomaMartin Köhler, Christine Greil, Michael Hudecek, et al.
Annals of Hematology|March 17, 2023
Safe and successful CAR T-cell therapy targeting BCMA in a multiple myeloma patient requiring hemodialysisRalph Wäsch, Tim Strüssmann, Claudia Wehr, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2010
Therapeutic drug monitoring of posaconazole in hematology patients: experience with a new high-performance liquid chromatography-based methodWerner Christian Neubauer, Monika Engelhardt, Armin König, et al.
Leukemia & Lymphoma|November 9, 2010
Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myelomaJens Hasskarl, Gabriele Ihorst, David De Pasquale, et al.
Pageof 23

Showing results (71-80 of 226) with videos related to

Sort By:
Pageof 23
Leukemia Research|June 21, 2011
Early and mature endothelial progenitors and VEGFR2+-cells in multiple myeloma: association with disease characteristics and variation in different cell compartmentsJosefina Udi, Dagmar Wider, Martina Kleber, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 21, 2020
Real-World Evaluation of Health-Related Quality of Life in Patients With Multiple Myeloma From GermanyMonika Engelhardt, Gabriele Ihorst, Moushmi Singh, et al.
British Journal of Haematology|May 27, 2022
Favourable outcomes of double-hit/double-expressor lymphoma and high-grade B-cell lymphoma, not otherwise specified after early dose-intensive treatment and up-front autologous stem cell transplantation: a single-centre retrospective experienceTim Strüßmann, Franziska Glatzki, Monika Engelhardt, et al.
Cancers|December 17, 2024
Clinical Characteristics, Cytogenetic Risks, and Prognoses of Young Multiple Myeloma Patients in the Era of Novel TherapiesNathalie Borst, Gabriele Ihorst, Sina Wenger, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2013
Validation of the Freiburg Comorbidity Index in 466 multiple myeloma patients and combination with the international staging system are highly predictive for outcomeMartina Kleber, Gabriele Ihorst, Barbara Gross, et al.
Annals of Hematology|March 26, 2018
Diffuse large B cell lymphoma (DLBCL): bilateral vanishing tibiaeReinhard Marks, Monika Engelhardt, Sven Hager, et al.
Cancer|February 7, 2018
Current developments in immunotherapy in the treatment of multiple myelomaMartin Köhler, Christine Greil, Michael Hudecek, et al.
Annals of Hematology|March 17, 2023
Safe and successful CAR T-cell therapy targeting BCMA in a multiple myeloma patient requiring hemodialysisRalph Wäsch, Tim Strüssmann, Claudia Wehr, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2010
Therapeutic drug monitoring of posaconazole in hematology patients: experience with a new high-performance liquid chromatography-based methodWerner Christian Neubauer, Monika Engelhardt, Armin König, et al.
Leukemia & Lymphoma|November 9, 2010
Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myelomaJens Hasskarl, Gabriele Ihorst, David De Pasquale, et al.
Pageof 23